INSPIRE Pipeline™ Shield Post Approval Study
NCT: NCT05071963 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.
Frequently Asked Questions
What is INSPIRE Pipeline™ Shield Post Approval Study?
INSPIRE Pipeline™ Shield Post Approval Study is a clinical trial registered under NCT05071963. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05071963?
The current status of NCT05071963 (INSPIRE Pipeline™ Shield Post Approval Study) is: ACTIVE_NOT_RECRUITING.
When did INSPIRE Pipeline™ Shield Post Approval Study start?
INSPIRE Pipeline™ Shield Post Approval Study started on 2021-12-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.